Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- OTC NEWS IN BRIEF
March 7, 2005
- Aiming for Sales of \100 Bil. in 2005: Mr Ohsawa of NBI
March 7, 2005
- DIAGNOSTIC NEWS IN BRIEF
March 7, 2005
- Korosho Submits Study Proposal on Use of Unapproved Drugs
March 7, 2005
- Eisai Establishes Marketing Subsidiary in Italy
March 7, 2005
- 5-Year Plan for New Basic Pharm. Research Institute Compiled
March 7, 2005
- MEDICAL DEVICE NEWS IN BRIEF
March 7, 2005
- 8,320 ADR Cases Reported by Makers in Aug.-Nov. 2004
March 7, 2005
- Japanese Healthcare Q&A (13)
March 7, 2005
- Korosho Presents Outline of New Clinical Trial Framework
March 7, 2005
- Daiichi Sankyo to Be Formed This October
March 7, 2005
- Fujisawa to Transfer Marketing of 11 Products to 3 Companies
February 28, 2005
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
February 28, 2005
- Daiichi Suntory Transfer Sales of Farom to Maruho
February 28, 2005
- Meet the Leaders (40)
February 28, 2005
- BUSINESS NEWS IN BRIEF
February 28, 2005
- Sunrise Plan Aims at Sales of \360 Billion in 2010: Mr Nagayama of Chugai
February 28, 2005
- Transitional Period for Labeling Changes in Rx-only Drug Announced
February 28, 2005
- Korosho Issues Guide on Preparing Manufacturing Applications
February 28, 2005
- Drug Production Statistics Data to Be Reported More Promptly
February 28, 2005
ページ
Japan’s pharmaceutical policy appears to be entering a new phase. The government’s newly approved honebuto policy and growth strategy both…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…